Carson Wealth (CWM LLC)’s Kronos Bio KRON Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,072	Closed	-$2K	–	4205
2022 Q4	$2K	Buy	+1,072	New	+$2.47K	﹤0.01%	3579

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Carson Wealth (CWM LLC)'s KRON Position: Q1 2023 in Review

Carson Wealth (CWM LLC) sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 1,072 shares — an estimated $2K sold.

Carson Wealth (CWM LLC) first reported a position in KRON in Q4 2022 and held it in 1 quarter. The position peaked at $2K in Q4 2022. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

Carson Wealth (CWM LLC) reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 1,072 Kronos Bio shares in Q1 2023, an estimated $2K.
Carson Wealth (CWM LLC) first reported a position in Kronos Bio in Q4 2022 and held it in 1 quarter.
Carson Wealth (CWM LLC)'s Kronos Bio position peaked at $2K in Q4 2022.
87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2023, filed 1 May 2023.